Increase/Decrease in Cash: The total change in cash for the company over the given period.
Rallybio Corporation (RLYB) had Increase/Decrease in Cash of $17.47M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.86M |
|
$-8.98M |
|
-- |
|
$0.86M |
|
$33.92M |
|
$-33.06M |
|
$24.96M |
|
$-8.10M |
|
$-8.10M |
|
$-8.10M |
|
$-8.98M |
|
$-8.98M |
|
$-8.10M |
|
$-33.06M |
|
$-33.55M |
|
5.63M |
|
5.63M |
|
$-1.59 |
|
$-1.59 |
|
| Balance Sheet Financials | |
$61.25M |
|
$0.02M |
|
$1.01M |
|
$62.26M |
|
$4.22M |
|
-- |
|
$0.08M |
|
$4.30M |
|
$57.96M |
|
$57.96M |
|
$57.96M |
|
5.28M |
|
| Cash Flow Statement Financials | |
$-29.81M |
|
$47.27M |
|
$0.02M |
|
$13.90M |
|
$31.37M |
|
|
Increase/Decrease in Cash |
$17.47M |
$5.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3853.61% |
|
-3853.61% |
|
-3909.67% |
|
-944.52% |
|
-1046.39% |
|
$-29.81M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-15.49% |
|
-15.49% |
|
-14.42% |
|
-15.49% |
|
$10.97 |
|
$-5.30 |
|
$-5.30 |
|